Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 14 | 2025 | 1306 | 1.660 |
Why?
|
| Glioma | 9 | 2023 | 494 | 1.610 |
Why?
|
| Glioblastoma | 6 | 2025 | 371 | 1.190 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2025 | 79 | 0.980 |
Why?
|
| Telomere-Binding Proteins | 2 | 2021 | 44 | 0.750 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2025 | 1272 | 0.750 |
Why?
|
| Carcinogenesis | 3 | 2023 | 336 | 0.750 |
Why?
|
| Intracranial Aneurysm | 2 | 2020 | 89 | 0.700 |
Why?
|
| Anterior Cerebral Artery | 1 | 2020 | 6 | 0.640 |
Why?
|
| Cerebral Angiography | 2 | 2020 | 106 | 0.600 |
Why?
|
| Sex Characteristics | 1 | 2021 | 323 | 0.580 |
Why?
|
| Mutation | 11 | 2025 | 6099 | 0.550 |
Why?
|
| Cerebrovascular Disorders | 1 | 2015 | 111 | 0.440 |
Why?
|
| Transcriptome | 2 | 2021 | 1103 | 0.430 |
Why?
|
| Cell Proliferation | 2 | 2023 | 2465 | 0.430 |
Why?
|
| Meningioma | 3 | 2022 | 151 | 0.420 |
Why?
|
| Meningeal Neoplasms | 3 | 2022 | 220 | 0.410 |
Why?
|
| Neurosurgical Procedures | 2 | 2019 | 322 | 0.400 |
Why?
|
| Genetic Linkage | 1 | 2015 | 461 | 0.390 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 371 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2015 | 363 | 0.380 |
Why?
|
| Family | 1 | 2015 | 589 | 0.340 |
Why?
|
| Ependymoma | 2 | 2022 | 137 | 0.330 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2020 | 41 | 0.270 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 802 | 0.260 |
Why?
|
| Aged | 11 | 2025 | 21025 | 0.190 |
Why?
|
| SOX9 Transcription Factor | 1 | 2022 | 82 | 0.170 |
Why?
|
| Cell Cycle | 2 | 2021 | 594 | 0.170 |
Why?
|
| Middle Aged | 9 | 2025 | 28601 | 0.170 |
Why?
|
| Adult | 9 | 2025 | 31282 | 0.160 |
Why?
|
| Astrocytoma | 1 | 2021 | 101 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 1545 | 0.160 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 34 | 0.150 |
Why?
|
| Male | 12 | 2025 | 64957 | 0.150 |
Why?
|
| Female | 13 | 2025 | 70963 | 0.150 |
Why?
|
| Oligodendroglioma | 2 | 2016 | 25 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 357 | 0.150 |
Why?
|
| Humans | 23 | 2025 | 131163 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2022 | 760 | 0.140 |
Why?
|
| Somatosensory Cortex | 1 | 2019 | 54 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 713 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 195 | 0.140 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 236 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 713 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 155 | 0.130 |
Why?
|
| Mice | 7 | 2023 | 18301 | 0.130 |
Why?
|
| Aspirin | 1 | 2018 | 211 | 0.130 |
Why?
|
| Healthcare Disparities | 2 | 2022 | 523 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 757 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 3763 | 0.130 |
Why?
|
| Young Adult | 4 | 2020 | 10103 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 292 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2023 | 3819 | 0.120 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2015 | 37 | 0.110 |
Why?
|
| DNA Repair | 1 | 2019 | 571 | 0.110 |
Why?
|
| DNA Damage | 1 | 2019 | 511 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2016 | 66 | 0.110 |
Why?
|
| Cubital Tunnel Syndrome | 1 | 2015 | 3 | 0.110 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 125 | 0.110 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 1586 | 0.110 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2015 | 71 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 67 | 0.110 |
Why?
|
| Middle Cerebral Artery | 1 | 2015 | 118 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2015 | 83 | 0.110 |
Why?
|
| Pedigree | 2 | 2015 | 1677 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 4738 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 194 | 0.100 |
Why?
|
| Animals | 7 | 2023 | 33912 | 0.100 |
Why?
|
| Neurons | 1 | 2023 | 1979 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 587 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 373 | 0.090 |
Why?
|
| Melanoma | 1 | 2019 | 931 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2065 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2022 | 26 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1722 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2015 | 1240 | 0.080 |
Why?
|
| Software | 1 | 2015 | 733 | 0.080 |
Why?
|
| ErbB Receptors | 2 | 2023 | 286 | 0.080 |
Why?
|
| Prognosis | 4 | 2020 | 4886 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2022 | 248 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2020 | 5063 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1692 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2018 | 3711 | 0.070 |
Why?
|
| Radiotherapy | 2 | 2019 | 119 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2015 | 1559 | 0.070 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2019 | 97 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 6797 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2022 | 915 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2020 | 1483 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2023 | 1590 | 0.060 |
Why?
|
| Disease Progression | 2 | 2023 | 2200 | 0.060 |
Why?
|
| Adolescent | 2 | 2020 | 20987 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2022 | 17753 | 0.050 |
Why?
|
| DNA Copy Number Variations | 2 | 2019 | 1029 | 0.050 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2022 | 37 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2023 | 104 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2023 | 152 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1801 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 2026 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2022 | 111 | 0.040 |
Why?
|
| Potassium | 1 | 2023 | 263 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2023 | 270 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2022 | 201 | 0.040 |
Why?
|
| Brain | 2 | 2023 | 3175 | 0.040 |
Why?
|
| Axons | 1 | 2023 | 386 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 587 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 118 | 0.040 |
Why?
|
| Synapses | 1 | 2023 | 425 | 0.040 |
Why?
|
| Clone Cells | 1 | 2020 | 153 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2019 | 5 | 0.040 |
Why?
|
| Oncogene Fusion | 1 | 2019 | 25 | 0.040 |
Why?
|
| Metabolic Flux Analysis | 1 | 2019 | 12 | 0.040 |
Why?
|
| Karnofsky Performance Status | 1 | 2019 | 13 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4697 | 0.040 |
Why?
|
| International Agencies | 1 | 2018 | 28 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 59 | 0.040 |
Why?
|
| Telomerase | 1 | 2019 | 154 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 142 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2019 | 146 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2019 | 324 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 633 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 180 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 633 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 700 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2023 | 1075 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 975 | 0.030 |
Why?
|
| Seizures | 1 | 2023 | 890 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2019 | 245 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1591 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1071 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 355 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 326 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1216 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 407 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2016 | 94 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 1011 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1207 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 3748 | 0.030 |
Why?
|
| Ulnar Nerve | 1 | 2015 | 8 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 889 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2552 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1077 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 953 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2019 | 991 | 0.020 |
Why?
|
| Age Factors | 1 | 2019 | 2825 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 1621 | 0.020 |
Why?
|
| Lung | 1 | 2020 | 1535 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 818 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3359 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 464 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5196 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1939 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6459 | 0.020 |
Why?
|
| Exome | 1 | 2014 | 1061 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2019 | 2406 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12936 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 3436 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3147 | 0.010 |
Why?
|